e-learning
resources
Vienna 2009
Monday, 14.09.2009
Severe asthma and its treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A new cause of difficult to treat asthma
M. E. Heuvers, H. J. Kan, H. C. Hoogsteden, P. T. W. van Hal (Rotterdam, Netherlands)
Source:
Annual Congress 2009 - Severe asthma and its treatment
Session:
Severe asthma and its treatment
Session type:
E-Communication Session
Number:
1865
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. E. Heuvers, H. J. Kan, H. C. Hoogsteden, P. T. W. van Hal (Rotterdam, Netherlands). A new cause of difficult to treat asthma. Eur Respir J 2009; 34: Suppl. 53, 1865
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
VAN HAL Peter - 14.09.2009 10:33
MBL deficiency in asthma
dear Lous, Thank you for your question. In all patients in whom all known and described causes of difficult to treat asthma are excluded we think that persistant complaints may be caused by an MBL deficiency, especially in asthmatics patients with recurrent infections. regards, peter
RIJSSENBEEK-NOUWENS Lucia H - 13.09.2009 10:20
Lous Rijssenbeek Nederlands AsthmacentrumDavos
Thank you very much for your interesting poster. Would you recomment to measure MBL in all patients with difficult to treat asthma?
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Phenotypes in difficult to treat asthma
Source: Annual Congress 2009 - Phenotype-driven asthma treatment in children
Year: 2009
Impact of comorbidities in difficult to treat asthma
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010
What is difficult asthma?
Source: Annual Congress 2003 - Difficult paediatric asthma
Year: 2003
Difficult to treat asthma
Source: Annual Congress 2006 - Clinical year in review
Year: 2006
Mild persistent asthma: to treat or not to treat regularly?
Source: ERS Live 2007
Year: 2007
Osteoporosis in the difficult to treat asthma population
Source: Annual Congress 2007 - Assessment and outcomes in non-COPD patients
Year: 2007
A difficult case: distinctions between difficult asthma, true severe asthma and overlap
Source: International Congress 2019 – PG11 Severe paediatric asthma
Year: 2019
Is difficult asthma still clinically meaningful?
Source: Eur Respir J 2006; 28: 897-899
Year: 2006
No identifiable risk factors for lung remodelling in children with difficult to treat asthma
Source: Annual Congress 2010 - Risk factors for allergic diseases in children
Year: 2010
What is ‘mild asthma’, and how common is it?
Source: International Congress 2018 – The complexities of managing mild asthma
Year: 2018
Component-resolved allergy diagnostics identify phenotypes in problematic severe childhood asthma
Source: Annual Congress 2011 - Risk and detection of childhood asthma and allergy
Year: 2011
How can we better treat infective exacerbations of COPD?
Source: Annual Congress 2012 - Prevention and treatment of infective exacerbations of COPD
Year: 2012
Can flexible combination therapy reduce severe asthma exacerbations associated with common colds?
Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections
Year: 2010
Ciclosporin as a steroid sparing agent in children with difficult to treat asthma
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009
Prevalence of fungal infections among patients with difficult to treat asthma in Egypt
Source: Eur Respir J 2005; 26: Suppl. 49, 376s
Year: 2005
The impact of breathing therapy in those with difficult asthma
Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease
Year: 2019
Nasal polyps as possible target to achieve the best biological treatment choice in severe asthma
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Exsmoking discriminates between patients with difficult asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 35s
Year: 2003
Diagnosing, treating and preventing severe asthma
Source: International Congress 2017 – State of the art session: "Airway diseases"
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept